Mikkael Sekeres

43PUBLICATIONS
271CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursMedical mycologyQuantum optics and quantum optomechanicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 29, 2026
Clinical and Genomic Convergence of High-Risk CCUS and Lower-Risk Myelodysplastic Syndromes/Neoplasms.

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Apr 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

|Apr 08, 2026
Quizartinib for patients with newly diagnosed FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First.

Mark J Levis, Harry P Erba, Pau Montesinos

|Feb 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study.

Amy E DeZern, Nancy Gillis, Michael Otterstatter

Pageof 8

Frequent Collaborators

16 joint publications

Rami S Komrokji

8 joint publications

David Sallman

8 joint publications

Valeria Santini

7 joint publications

Uwe Platzbecker